ArticleBioengineering (Basel, Switzerland)2025
Feature Feedback-Based Pseudo-Label Learning for Multi-Standards in Clinical Acne Grading.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Accurate acne grading is critical in optimizing therapeutic decisions yet remains challenging due to lesion ambiguity and subjective clinical assessments. This study proposes the Feature Feedback-Based Pseudo-Label Learning (FF-PLL) framework to address these limitations through three innovations: (1) an acne feature feedback (AFF) architecture with iterative pseudo-label refinement to improve the training robustness, enhance the pseudo-label quality, and increase the feature diversity; (2) all-facial skin segmentation (AFSS) to reduce background noise, enabling precise lesion feature extraction; and (3) the AcneAugment (AA) strategy to foster model generalization by introducing diverse acne lesion representations. Experiments on the ACNE04 and ACNE-ECKH benchmark datasets demonstrate the superiority of the proposed framework, achieving accuracy of 87.33% on ACNE04 and 67.50% on ACNE-ECKH. Additionally, the model attains sensitivity of 87.31%, specificity of 90.14%, and a Youden index (YI) of 77.45% on ACNE04. These advancements establish FF-PLL as a clinically viable solution for standardized acne assessment, bridging critical gaps between computational dermatology and practical healthcare needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.